Promoting clearance of intracellular excessive tau is a potential therapeutic strategy for treating Alzheimer's disease. In this work, we designed and synthesized a cyclen-hybrid artificial 'hydrolase' I1-Cu(II) to cleave tau in vitro. Furthermore, a cell-permeable 'hydrolase' I2-Cu(II), derived from I1-Cu(II), was also synthesized to cleave intracellular tau proteins.
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Huang, Yadong
;
Mucke, Lennart
论文数: 0引用数: 0
h-index: 0
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Huang, Yadong
;
Mucke, Lennart
论文数: 0引用数: 0
h-index: 0
机构:
Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USAGladstone Inst Neurol Dis, San Francisco, CA 94158 USA